[RAS mutations at the molecular tumor conference].

Abstract excerpt

Members of the rat sarcoma (RAS) gene family belong to the most frequently mutated genes that drive pathogenesis and therapy response. As the discovery of their malignant potential dates back more than three decades, cellular mutated RAS genes and their products belong to the best characterized cancer genes. Despite urgent clinical needs, RAS therapies are still elusive and limited to preclinical studies....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Molecular Targeted Therapy
• Share to Mutation
• Share to Neoplasms